Bone Sialoprotein (BSP), A129-I139 Antibody from KERAFAST, INC.

Search, find, compare suppliers for anti-Bone Sialoprotein (BSP), A129-I139 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityBone Sialoprotein (BSP), A129-I139
CloneLF-100
Host SpeciesRabbit
Reactive Specieshuman, monkey, dog, rat
Isotypen/a
Formatunconjugated
Size100uL
Concentrationn/a
ApplicationsWB 1:2000, IHC 1:200
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Bone Sialoprotein (BSP), A129-I139 [LF-100] Antibody. Target: Bone Sialoprotein (BSP), human. Epitope: AIQLPKKAGDI
ImmunogenPeptide
Other Namesn/a
Gene, Accession #Accession: P21815
Catalog #ENH074-FP
Price$336
Order / More InfoBone Sialoprotein (BSP), A129-I139 Antibody from KERAFAST, INC.
Product Specific References
  1. Fisher LW, Stubbs JT 3rd, Young MF. Antisera and cDNA probes to human andcertain animal model bone matrix noncollagenous proteins. Acta Orthop ScandSuppl. 1995 Oct;266:61-5. PubMed PMID: 8553864.
  2. Waltregny D, Bellahcene A, Van Riet I, Fisher LW, Young M, Fernandez P, DeweW, de Leval J, Castronovo V. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst. 1998 Jul1;90(13):1000-8. PubMed PMID: 9665149.
  3. Fedarko NS, Fohr B, Robey PG, Young MF, Fisher LW. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem. 2000 Jun 2;275(22):16666-72.
  4. Jain A, Karadag A, Fisher LW, Fedarko NS. Structural requirements for bonesialoprotein binding and modulation of matrix metalloproteinase-2. Biochemistry. 2008 Sep 23;47(38):10162-70.
  5. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000 Dec5;97(25):13625-30. PubMed PMID: 11087820; PubMed Central PMCID: PMC17626.
  6. Gorski JP, Huffman NT, Cui C, Henderson EP, Midura RJ, Seidah NG. Potentialrole of proprotein convertase SKI-1 in the mineralization of primary bone. Cells Tissues Organs. 2009;189(1-4):25-32. doi: 10.1159/000151723. Epub 2008 Aug 26.PubMed PMID: 18728345; PubMed Central PMCID: PMC2824183.
  7. Petri AD, Teixeira LN, Crippa GE, Beloti MM, de Oliveira PT, Rosa AL. Effects of low-level laser therapy on human osteoblastic cells grown on titanium. BrazDent J. 2010;21(6):491-8. PubMed PMID: 21271038.
KERAFAST, INC.
KERAFAST, INC.
KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826

info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com

https://www.kerafast.com
Profile of KERAFAST, INC.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.